Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 106, Issue 4, Pages 666-672

出版商

Springer Nature

发表日期

2012-01-13

DOI

10.1038/bjc.2011.590

参考文献

查看 4 条相关文献

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now